Crystal structures of acetylcholinesterase in complex with HI-6, Ortho-7 and obidoxime: structural basis for differences in the ability to reactivate tabun conjugates.

Inhibition of acetylcholinesterase (AChE) by organophosphorus compounds (OPs) such as pesticides and nerve agents causes acute toxicity or death of the intoxicated individual. The inhibited AChE may be reactivated by certain oximes as antidotes for clinical treatment of OP-intoxications. Crystal structures of the oximes HI-6, Ortho-7 and obidoxime in complex with Mus musculus acetylcholinesterase (mAChE) reveal different roles of the peripheral anionic site (PAS) in the binding of the oximes. A limited structural change of the side chains of Trp286 and Asp74 facilitates the intercalation of the 4-carboxylamide pyridinium ring of HI-6 between the side chains of Tyr124 and Trp286. The 2-carboxyimino pyridinium ring of HI-6 is accommodated at the entrance of the catalytic site with the oximate forming a hydrogen bond to the main-chain nitrogen atom of Phe295. In contrast to HI-6, the coordination of Ortho-7 and obidoxime within the PAS is facilitated by an extended structural change of Trp286 that allows one of the carboxyimino pyridinium rings to form a cation-pi interaction with the aromatic groups of Tyr72 and Trp286. The central chain of Ortho-7 and obidoxime is loosely coordinated in the active-site gorge, whereas the second carboxyimino pyridinium ring is accommodated in the vicinity of the phenol ring of Tyr337. The structural data clearly show analogous coordination of Ortho-7 and obidoxime within the active-site gorge of AChE. Different ability to reactivate AChE inhibited by tabun is shown in end-point reactivation experiments where HI-6, Ortho-7 and obidoxime showed an efficiency of 1, 45 and 38%, respectively. The low efficiency of HI-6 and the significantly higher efficiency of Ortho-7 and obidoxime may be explained by the differential binding of the oximes in the PAS and active-site gorge of AChE.

[1]  I. Tsigelny,et al.  Analysis of cholinesterase inactivation and reactivation by systematic structural modification and enantiomeric selectivity. , 1999, Chemico-biological interactions.

[2]  P. Taylor,et al.  Two possible orientations of the HI-6 molecule in the reactivation of organophosphate-inhibited acetylcholinesterase. , 2003, Biochemical pharmacology.

[3]  J. Sussman,et al.  Crystal structures of aged phosphonylated acetylcholinesterase: nerve agent reaction products at the atomic level. , 1999, Biochemistry.

[4]  Zoran Radić,et al.  Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site , 2003, The EMBO journal.

[5]  A. Goldman,et al.  Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein , 1991, Science.

[6]  P. Sadler,et al.  Protection by Oximes of bis-Pyridinium Ions against Lethal Diisopropyl Phosphonofluoridate Poisoning , 1958, Nature.

[7]  S. Brimijoin,et al.  Cholinesterase Reactivation in Vivo with a Novel Bis-Oxime Optimized by Computer-Aided Design , 2003, Journal of Pharmacology and Experimental Therapeutics.

[8]  B. Holmstedt.  Synthesis and pharmacology of dimethylamido-ethoxy-phosphoryl cyanide (tabun) together with a description of some allied anticholinesterase compounds containing the N-P bond. , 1951, Acta physiologica Scandinavica. Supplementum.

[9]  K. Kuča,et al.  Specification of the structure of oximes able to reactivate tabun-inhibited acetylcholinesterase. , 2004, Basic & clinical pharmacology & toxicology.

[10]  C. Akfur,et al.  Structural changes of phenylalanine 338 and histidine 447 revealed by the crystal structures of tabun-inhibited murine acetylcholinesterase. , 2006, Biochemistry.

[11]  C. Hall,et al.  Phosphorus stereochemistry : Mechanistic implications of the observed stereochemistry of bond forming and breaking processes at phosphorus in some 5- and 6-membered cyclic phosphorus esters , 1980 .

[12]  Wolfgang Kabsch,et al.  Evaluation of Single-Crystal X-ray Diffraction Data from a Position-Sensitive Detector , 1988 .

[13]  N. Ariel,et al.  Allosteric modulation of acetylcholinesterase activity by peripheral ligands involves a conformational transition of the anionic subsite. , 1995, Biochemistry.

[14]  P. Sadler,et al.  New Potent Reactivators of Acetocholinesterase Inhibited by Tetraethyl Pyrophosphate , 1958, Nature.

[15]  Zoran Radić,et al.  Freeze-frame inhibitor captures acetylcholinesterase in a unique conformation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[16]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[17]  L. D. de Jong,et al.  The bispyridinium-dioxime HLö-7. A potent reactivator for acetylcholinesterase inhibited by the stereoisomers of tabun and soman. , 1989, Biochemical pharmacology.

[18]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[19]  P. Taylor,et al.  Mechanism of oxime reactivation of acetylcholinesterase analyzed by chirality and mutagenesis. , 2000, Biochemistry.

[20]  G Vriend,et al.  WHAT IF: a molecular modeling and drug design program. , 1990, Journal of molecular graphics.

[21]  P. Eyer,et al.  Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates , 2002, Archives of Toxicology.

[22]  I. Tsigelny,et al.  Amino Acid Residues Controlling Reactivation of Organophosphonyl Conjugates of Acetylcholinesterase by Mono- and Bisquaternary Oximes (*) , 1995, The Journal of Biological Chemistry.

[23]  P. Eyer,et al.  Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes. , 2004, Biochemical pharmacology.

[24]  N. Ariel,et al.  Acetylcholinesterase peripheral anionic site degeneracy conferred by amino acid arrays sharing a common core. , 1994, The Journal of biological chemistry.

[25]  A. Shafferman,et al.  Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives. , 1996, Molecular pharmacology.

[26]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[27]  A. Brunger.  Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. , 1992 .

[28]  Wolfgang Kabsch,et al.  Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants , 1993 .

[29]  P. Eyer,et al.  HLö 7 dimethanesulfonate, a potent bispyridinium-dioxime against anticholinesterases , 2005, Archives of Toxicology.

[30]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[31]  I. Wilson,et al.  Oximes of the Pyridine Series1 , 1957 .

[32]  B. Ginsburg,et al.  A powerful reactivator of alkylphosphate-inhibited acetylcholinesterase. , 1955, Biochimica et biophysica acta.

[33]  J. Sussman,et al.  Reaction Products of Acetylcholinesterase and VX Reveal a Mobile Histidine in the Catalytic Triad , 1999 .

[34]  S. Brimijoin,et al.  Rational design of alkylene-linked bis-pyridiniumaldoximes as improved acetylcholinesterase reactivators. , 2003, Chemistry & biology.